{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:47:57Z","timestamp":1790380077893,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Asociaci\u00f3n de Amigos de la Universidad de Navarra (ADA foundation)"},{"name":"Tropical Health Institute (University of Navarra)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jdermsci.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T09:08:45Z","timestamp":1531904925000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Combination of paromomycin plus human anti-TNF-\u03b1 antibodies to control the local inflammatory response in BALB\/ mice with cutaneous leishmaniasis lesions"],"prefix":"10.1016","volume":"92","author":[{"given":"Juana","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Fern\u00e1ndez-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Sanmart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nguewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Irache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Larrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro","family":"Espuelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jdermsci.2018.07.005_bib0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pim.12007","article-title":"Tissue damage and immunity in cutaneous leishmaniasis","volume":"34","author":"Nylen","year":"2012","journal-title":"Parasite Immunol."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.07.005_bib0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/20477724.2016.1232042","article-title":"Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review","volume":"110","author":"Maspi","year":"2016","journal-title":"Pathog. Glob. Health"},{"issue":"9","key":"10.1016\/j.jdermsci.2018.07.005_bib0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri.2016.72","article-title":"Cutaneous leishmaniasis: immune responses in protection and pathogenesis","volume":"16","author":"Scott","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2018.07.005_bib0020","first-page":"16","article-title":"Characterization of the histopathologic features in patients in the early and late phases of cutaneous leishmaniasis","author":"Saldanha","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jdermsci.2018.07.005_bib0025","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/502980","article-title":"CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells","volume":"193","author":"Campanelli","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jdermsci.2018.07.005_bib0030","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ijpara.2010.03.011","article-title":"The role of TNF in parasitic diseases: still more questions than answers","volume":"40","author":"Korner","year":"2010","journal-title":"Int. J. Parasitol."},{"issue":"12","key":"10.1016\/j.jdermsci.2018.07.005_bib0035","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor-necrosis-factor-alpha synergizes with Ifn-gamma in mediating killing of leishmania-major through the induction of nitric-oxide","volume":"145","author":"Liew","year":"1990","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.07.005_bib0040","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.166.6.4012","article-title":"Rapidly fatal leishmaniasis in resistant C57BL\/6 mice lacking TNF","volume":"166","author":"Wilhelm","year":"2001","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jdermsci.2018.07.005_bib0045","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/iai.62.4.1414-1420.1994","article-title":"Tumor necrosis factor alpha (TNF-alpha) and TNF-beta and their receptors in experimental cutaneous leishmaniasis","volume":"62","author":"de Kossodo","year":"1994","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.07.005_bib0050","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4049\/jimmunol.153.2.768","article-title":"Role and effect of Tnf-alpha in experimental visceral leishmaniasis","volume":"153","author":"Tumang","year":"1994","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.07.005_bib0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4269\/ajtmh.2011.10-0680","article-title":"Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous Leishmaniasis","volume":"85","author":"Oliveira","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"11","key":"10.1016\/j.jdermsci.2018.07.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005116","article-title":"Gene expression profile of high IFN-gamma producers stimulated with leishmania braziliensis identifies genes associated with cutaneous leishmaniasis","volume":"10","author":"Carneiro","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"12","key":"10.1016\/j.jdermsci.2018.07.005_bib0065","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1128\/IAI.70.12.6734-6740.2002","article-title":"Up-regulation of Th1-type responses in mucosal leishmaniasis patients","volume":"70","author":"Bacellar","year":"2002","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.07.005_bib0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/1469-0691.12095","article-title":"The therapeutic potential of immune cross-talk in leishmaniasis","volume":"19","author":"Hartley","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.07.005_bib0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.semarthrit.2013.01.006","article-title":"Leishmaniasis during anti-tumor necrosis factor therapy: report of 4 cases and review of the literature (additional 28 cases)","volume":"43","author":"Guedes-Barbosa","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.jdermsci.2018.07.005_bib0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1742-481X.2006.00233.x","article-title":"Topical application of the tumour necrosis factor-alpha antibody infliximab improves healing of chronic wounds","volume":"3","author":"Streit","year":"2006","journal-title":"Int. Wound J."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.07.005_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"5","key":"10.1016\/j.jdermsci.2018.07.005_bib0090","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2217\/imt.09.40","article-title":"Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature","volume":"1","author":"Okwor","year":"2009","journal-title":"Immunotherapy"},{"issue":"4643","key":"10.1016\/j.jdermsci.2018.07.005_bib0095","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1126\/science.6701528","article-title":"Identification of an infective stage of Leishmania promastigotes","volume":"223","author":"Sacks","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.jdermsci.2018.07.005_bib0100","first-page":"50966","article-title":"Bone marrow-derived macrophage production","volume":"81","author":"Trouplin","year":"2013","journal-title":"J. Visualized Exp.: JoVE"},{"key":"10.1016\/j.jdermsci.2018.07.005_bib0105","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jim.2017.06.012","article-title":"Optimized incubation regime for nitric oxide measurements in murine macrophages using the Griess assay","volume":"449","author":"Schmolz","year":"2017","journal-title":"J. Immunol. Methods"},{"issue":"6","key":"10.1016\/j.jdermsci.2018.07.005_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067078","article-title":"Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jdermsci.2018.07.005_bib0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"issue":"8","key":"10.1016\/j.jdermsci.2018.07.005_bib0120","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/gut.2005.070060","article-title":"Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: in vivo and in vitro studies","volume":"55","author":"Larrea","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jdermsci.2018.07.005_bib0125","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13071-016-1413-9","article-title":"Study of Leishmania pathogenesis in mice: experimental considerations","volume":"9","author":"Loeuillet","year":"2016","journal-title":"Parasites Vectors"},{"issue":"5","key":"10.1016\/j.jdermsci.2018.07.005_bib0130","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.immuni.2013.04.010","article-title":"The C-type lectin receptors dectin-1, MR, and SIGNR3 contribute both positively and negatively to the macrophage response to Leishmania infantum","volume":"38","author":"Lefevre","year":"2013","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.jdermsci.2018.07.005_bib0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","volume":"11","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.jdermsci.2018.07.005_bib0140","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1093\/jac\/dks220","article-title":"Combination of paromomycin and miltefosine promotes TLR4-dependent induction of antileishmanial immune response in vitro","volume":"67","author":"Das","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.jdermsci.2018.07.005_bib0145","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/bph.12530","article-title":"TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin-miltefosine combination therapy in visceral leishmaniasis","volume":"171","author":"Das","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.jdermsci.2018.07.005_bib0150","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.4049\/jimmunol.160.8.3729","article-title":"Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12","volume":"160","author":"Shnyra","year":"1998","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.07.005_bib0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.jdermsci.2018.07.005_bib0160","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/wound.2012.0407","article-title":"Disclosure of the culprits: macrophages\u2014versatile regulators of wound healing","volume":"2","author":"Sindrilaru","year":"2013","journal-title":"Adv. Wound Care"},{"issue":"12","key":"10.1016\/j.jdermsci.2018.07.005_bib0165","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.dld.2013.06.007","article-title":"Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice","volume":"45","author":"Lopetuso","year":"2013","journal-title":"Digest. Liver Dis."},{"issue":"5","key":"10.1016\/j.jdermsci.2018.07.005_bib0170","doi-asserted-by":"crossref","first-page":"E844","DOI":"10.1152\/ajpendo.00029.2011","article-title":"Inactivation of TNF-alpha ameliorates diabetic neuropathy in mice","volume":"301","author":"Yamakawa","year":"2011","journal-title":"Am. J. Physiol.-Endocr. Metab."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.07.005_bib0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/cei.12872","article-title":"Anti-inflammatory effects of infliximab in mice are independent of tumour necrosis factor alpha neutralization","volume":"187","author":"Assas","year":"2017","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jdermsci.2018.07.005_bib0180","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ncomms2566","article-title":"Aldara activates TLR7-independent immune defence","volume":"4","author":"Walter","year":"2013","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.07.005_bib0185","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/jac\/dkw012","article-title":"Drug permeation and barrier damage in Leishmania-infected mouse skin","volume":"71","author":"Van Bocxlaer","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.jdermsci.2018.07.005_bib0190","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/jid.2014.396","article-title":"Proteome profiling of human cutaneous leishmaniasis lesion","volume":"135","author":"Da Silva Santos","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.jdermsci.2018.07.005_bib0195","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/jid.2014.305","article-title":"Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology","volume":"135","author":"Novais","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.jdermsci.2018.07.005_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179084","article-title":"A secondary wave of neutrophil infiltration causes necrosis and ulceration in lesions of experimental American cutaneous leishmaniasis","volume":"12","author":"Peniche","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jdermsci.2018.07.005_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003889","article-title":"A review: the current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis","volume":"9","author":"Mears","year":"2015","journal-title":"PLoS Negl. Trop Dis."},{"issue":"5","key":"10.1016\/j.jdermsci.2018.07.005_bib0210","first-page":"597","article-title":"Activation of human keratinocytes by Leishmania spp.: divergent effects of leishmania infantum versus leishmania major","volume":"95","author":"Scorza","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"3","key":"10.1016\/j.jdermsci.2018.07.005_bib0215","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jconrel.2010.04.023","article-title":"Reduction in inflammation in the footpad of carrageenan treated mice following the topical administration of anti-TNF molecules formulated in a micro-emulsion","volume":"145","author":"Himes","year":"2010","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.jdermsci.2018.07.005_bib0220","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.xphs.2017.03.012","article-title":"Development of topical delivery systems for flightless neutralizing antibody","volume":"106","author":"Haidari","year":"2017","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jdermsci.2018.07.005_bib0225","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/jid.2012.457","article-title":"Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita","volume":"133","author":"Kopecki","year":"2013","journal-title":"J. Invest. Dermatol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118302792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181118302792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T04:49:06Z","timestamp":1760330946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181118302792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0923181118302792"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.07.005","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of paromomycin plus human anti-TNF-\u03b1 antibodies to control the local inflammatory response in BALB\/ mice with cutaneous leishmaniasis lesions","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}